AstraZeneca raises sales forecast after second-quarter cancer drug, China boost

AstraZeneca Plc raised its product sales forecast for 2019 on Thursday after second-quarter results beat analysts' expectations, thanks to strong sales from cancer medicines and emerging markets, especially China.